Hydrocortisone Valerate (Hydroval) shortage status
Discontinued
Source: Health Canada shortage reports · Updated Jul 9, 2026
Hydrocortisone Valerate products have been discontinued in Canada. See the reports below for which products and when.
A topical corticosteroid used to relieve skin inflammation and itching.
Products affected
0 / 2
Reports on file
32
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
HYDROVAL OINTMENT 0.2%
0.2% · OINTMENT · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242985 · ended Dec 22, 2022 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Sep 7, 2022 · Disruption of the manufacture of the drug.
reversed
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Jun 8, 2021 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Jan 22, 2021 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Nov 27, 2020 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL OINTMENT 0.2%
0.2% · OINTMENT · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242985 · ended Nov 27, 2020 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Nov 27, 2020 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Oct 2, 2020 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL OINTMENT 0.2%
0.2% · OINTMENT · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242985 · ended Oct 2, 2020 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended Jun 19, 2020 · Disruption of the manufacture of the drug.
Resolved
HYDROVAL CREAM 0.2%
0.2% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02242984 · ended May 6, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 32 reports. All reports are on file with Health Canada.
What's happening
One or more Hydrocortisone Valerate products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.
Hydrocortisone Valerate is classified under “CORTICOSTEROIDS, PLAIN” (ATC D07AA).
Recent changes
No changes recorded yet.
Common questions
What is Hydrocortisone Valerate used for?
A topical corticosteroid used to relieve skin inflammation and itching.
When will Hydrocortisone Valerate be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Hydrocortisone Valerate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.